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The yeast Candida glabrata is a major opportunistic pathogen causing mucosal and
systemic infections in humans. Systemic infections caused by this yeast have high
mortality rates and are difficult to treat due to this yeast’s intrinsic and frequently
adapting antifungal resistance. To understand and treat C. glabrata infections, it is
essential to investigate the molecular basis of C. glabrata virulence and resistance.
We established an RNA interference (RNAi) system in C. glabrata by expressing the
Dicer and Argonaute genes from Saccharomyces castellii (a budding yeast with natural
RNAi). Our experiments with reporter genes and putative virulence genes showed that
the introduction of RNAi resulted in 30 and 70% gene-knockdown for the construct-
types antisense and hairpin, respectively. The resulting C. glabrata RNAi strain was
used for the screening of a gene library for new virulence-related genes. Phenotypic
profiling with a high-resolution quantification of growth identified genes involved in the
maintenance of cell integrity, antifungal drugs, and ROS resistance. The genes identified
by this approach are promising targets for the treatment of C. glabrata infections.
Keywords: Candida glabrata, pathogenic yeast, RNA interference, RNAi, gene library, antifungal drugs, virulence
factors, macrophages
INTRODUCTION
The yeast Candida glabrata is an opportunistic human pathogen that causes relatively benign
mucosal or fatal systemic infections. The incidence of infections caused by this Candida species
has significantly increased particularly in immune-deficient patients, in addition to those that
undergo chemotherapy, treated with broad-spectrum antibiotics for prolonged time, or have
undergone a higher number of invasive surgeries (Pfaller and Diekema, 2007). In healthy humans,
Candida species colonize the oral cavity, vagina, and gut (Mårdh et al., 2002; Moyes and
Naglik, 2011). In many studies, C. glabrata and C. albicans are considered the most common
causes of candidiasis (Fidel et al., 1999; Brunke and Hube, 2013). While C. glabrata is a
distant relative of C. albicans, it is a close relative of bakers’ yeast Saccharomyces cerevisiae
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(Dujon et al., 2004). In evolutionary time scales, C. glabrata
only “recently” became pathogenic (Brunke and Hube, 2013;
Ahmad et al., 2014). The mechanisms behind C. glabrata
pathogenicity are thus far not well understood, but appear
to differ greatly from C. albicans. Immune evasion strategies,
possibly via intracellular survival and replication in macrophages
contribute to the virulence of C. glabrata (Seider et al.,
2011, 2014; Brunke and Hube, 2013; Kasper et al., 2014).
C. glabrata also readily rearranges its genome (Ahmad et al.,
2014) at a frequency one order of magnitude higher than
in C. albicans (Gabaldón and Fairhead, 2018). Genome
rearrangements could be evolutionary advantageous for this
yeast, allowing it to adapt rapidly to its host environment and to
antifungal treatments.
Research focused on C. glabrata pathogenicity can
benefit greatly from the development of molecular tools.
In S. cerevisiae, the strategy of gene deletion has been
used for decades as an approach to study gene function.
However, Giaever et al. (2002) found that approximately 1000
mutants (representing ∼17% of all S. cerevisiae genes) failed
to grow as a result of a specific gene deletion in haploids,
proving that these genes are essential for this yeast. The
genome of C. glabrata has 5283 predicted coding sequences,
and extensive research has been devoted to the creation
of a whole genome deletion library for this haploid yeast
(Schwarzmüller et al., 2014). Large-scale gene deletions for
C. glabrata proved less feasible than for S. cerevisiae due to
gene essentiality or technical reasons (lower homologous
recombination rates). However it must be assumed that
C. glabrata contains a similar number of essential genes
as S. cerevisiae.
Other techniques, such as down-regulating gene expression
can provide alternative ways to study genes’ functions. The
RNA interference (RNAi), which relies on manipulating the
levels of a gene’s transcript, has become a widespread tool
to analyze the function of genes in organisms ranging from
protozoa to human. Unlike gene deletions, RNAi can be applied
to any gene, even those that are essential. It has, however, not
found many applications in baker’s yeast, which naturally lack
important components of the RNAi machinery (Drinnenberg
et al., 2009). The RNAi approach relies on the activity of two
proteins, Dicer (ribonuclease III) and Argonaute (the carrier
of small interfering RNA [siRNAs]). The process is initiated
by the cleavage of double stranded RNA (complementary to
the target transcript) by Dicer into siRNAs, which are then
loaded on Argonaute and, by base-pair interaction, target the
gene’s transcript. This ultimately interferes with gene expression
by down-regulation. RNAi is found widely in nature (plants,
animals, and fungi), and provides evolutionary advantages
by protecting these organisms from viruses, taking part in
gene silencing, heterochromatin organization, and chromosome
segregation (Tijsterman et al., 2002; Martienssen et al., 2005;
Moazed, 2009).
Remarkably, although RNAi is well preserved among some
fungi (Drinnenberg et al., 2009), it has been lost in several
budding yeasts such as S. cerevisiae and C. glabrata. The aim of
this study was to develop a RNAi system for C. glabrata and to
use it as a tool to identify and functionally analyze genes known
to be putatively required for virulence.
RESULTS
Introduction of RNAi Into C. glabrata
For the reconstitution of an RNAi mechanism in C. glabrata,
two heterologous Saccharomyces castellii genes, DCR1 and
AGO1 (coding for Dicer and Argonaute, correspondingly) were
introduced into the C. glabrata genome. For this purpose
we first evaluated the activity of several constitutive and
inducible promoters by their ability to induce expression of a
functional enzyme, deoxyribonucleoside kinase of Drosophila
melanogaster (Supplementary Figure S1, Methods). The dNK
gene encoding this enzyme was successfully expressed in
C. glabrata and different enzyme activity was observed when
expressed from different promoters (Supplementary Figure S1).
For the expression of DCR1 and AGO1 genes in the C. glabrata,
we used the strong constitutive promoters TEF1 and TDH3
of C. glabrata (Figure 1A and Supplementary Figure S1).
The plasmid carrying the DCR1 and AGO1 constructs (P1062,
Supplementary Table S2) was linearized by SphI and integrated
into the genome of three standard laboratory C. glabrata strains,
BG2, CBS138 and BG14 (Table 1).
To first prove that the RNAi pathway can function in
C. glabrata, we generated silencing constructs targeting the two
genes URA3 (encoding orotidine 5′-phosphate decarboxylase)
and ADE2 (encoding phosphoribosylaminoimidazole
carboxylase) in the C. glabrata genome. They are part of
the uracil (URA3 gene) and adenine (ADE2 gene) biosynthesis
pathway and are popular auxotrophic markers in yeast genetics.
Lack or loss of function of these genes products result in
following phenotypes: requirement of uracil/adenine for growth,
accumulation of p-ribosylaminoimidazolecarboxylate (red
pigment) in the absence of ADE2 transcript, and resistance to 5-
FOA without URA3. We used two different silencing constructs
for these genes (antisense and hairpin), which we introduced into
the lys2 auxotrophic variant of BG2 carrying RNAi genes (Y1662,
Table 1) by transforming it with integrative plasmids. The design
of silencing constructs was similar to that used by Drinnenberg
et al. (2009), were the antisense constructs consisted of 339 bp
of antisense DNA strand of the gene and hairpins had 339 bp
of both antisense and sense DNA strand separated by 79 bp
“loop” (Supplementary Data). SalI linearized the plasmids with
antisense constructs, and SmaI linearized hairpin plasmids before
the transformation. For the expression of silencing constructs
we selected the strong inducible C. glabrata promoter CUP1
(Figure 1A and Supplementary Figure S1).
Two to three selected transformants of the RNAi strain
carrying different silencing constructs were grown on different
selective media (Figure 1B). We observed a decreased growth
among transformants carrying antisense constructs (URA3,
ADE2) under conditions of CUP1 promoter induction (medium
supplemented with copper) on minimal medium lacking uracil
or adenine. For hairpin constructs (URA3, ADE2), a growth
inhibition by several orders of magnitudes was observed with
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FIGURE 1 | Introduction of RNA interference (RNAi) into C. glabrata. (A) Schematic view of the plasmid carrying the expression cassettes for the DCR1 and AGO1
genes of S. castellii (P1062), which was integrated into the genome; the DCR1 cassette consisted of the promoter TEF1 and the terminator CYC1 of C. glabrata; the
AGO1 cassette consisted of the promoter TDH3 and the terminator TDH3 of C. glabrata; the silencing constructs (antisense and hairpins) targeting two model genes
of the C. glabrata genome, URA3 and ADE2, were expressed under control of the inducible promoter CUP1 with the terminator CYC1, both of C. glabrata.
(B) Growth phenotypes of C. glabrata transformant carrying RNAi constructs for URA3 and ADE2 genes (hairpin [H] and antisense [A]). Serial dilutions of cells (OD600
1; 0.1; 0.01) were plated on different media with and without copper (YNB; YNB with adenine; YNB with 5-FOA and uracil); Strains are as follows: 1 – BG2; 2 –
Y1662 carrying P1028 (RNAi negative control); 3 – URA3 antisense-8; 4 – URA3 antisense-12; 5 – ADE2 antisense-5; 6 – ADE2 antisense-10; 7 – URA3 hairpin-4;
8 – URA3 hairpin-7; 9 – ADE2 hairpin-3; 10 – ADE2 hairpin-4; 11 – ADE2 hairpin-10. (C) Expression analysis of ADE2 and URA3 genes in RNAi transformants
performed by qRT-PCR. Gene expression was induced by addition of copper to the medium. Strains: control (Y1662 carrying P1028); ADE2 antisense; ADE2
hairpin; URA3 antisense; URA3 hairpin. The error bars represent standard deviation of two replicates. Corresponding primer pairs were used with cDNA: ACT1 gene
(OP33 and OP34), ADE2 (OP31 and OP32), URA3 (OP27 and OP28).
and without CUP1 promoter induction. Apparently, the CUP1
promoter was leaky (Supplementary Figure S1) and the hairpin
constructs had a strong effect on gene expression. In agreement
with this, silencing of the URA3 gene with the hairpins allowed
growth on 5-FOA (Figure 1B), a compound, which is toxic
to cells with an active URA3 gene. Further, ADE2 silencing
with hairpins resulted in accumulation of the red pigment
P-ribosylamino imidazole on adenine-limited media (10 mg/L),
which indicates a block in adenine synthesis (Figure 1B). These
results show a strong silencing of model target genes by both
URA3 and ADE2 hairpin constructs.
To confirm our phenotypic observations, the expression
of URA3 and ADE2 genes was studied by qRT-PCR in
transformants carrying either antisense or hairpin silencing
constructs (Figure 1C). Compared to the control strain, both
ADE2 antisense and URA3 antisense constructs caused 1.4-times
and 2-times down-regulation, respectively, of their target genes
specifically in the medium with copper (Figure 1C). In contrast,
gene expression in transformants with hairpin constructs was
repressed further than that even in the medium without copper,
with only slight additional increase in the presence of Cu
ions (Figure 1C).
The experiment showed that the reconstituted RNAi pathway
in C. glabrata is functional and can be applied for gene
silencing in this yeast.
Knock-Down of a Known Virulence Gene
In addition to model genes, we designed silencing constructs
for PUP1/CAGL0M12947g gene of C. glabrata to be tested in
our RNAi system in C. glabrata CBS 138 strain. The deletion of
this gene, encoding a mitochondria localized protein, decreases
the virulence of azole resistant strain DSY565 of C. glabrata in
an immuno-compromised mouse model (Vermitsky et al., 2006;
Ferrari et al., 2011). Both DSY565 and CBS 138 strains are
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TABLE 1 | Strains used in this study.
Laboratory
designation
Original name Origin Description Source
Y1092 CBS 138 (ATCC 2001) Wild type Reference strain
Y1630 BG2 Clinical isolate Wild type (Fidel et al., 1996) Kindly provided by
Cormack B.
Y1638 BG14 BG2 ura3 (Cormack and Falkow, 1999) Kindly
provided by Cormack B.
Y1636 Y1092 lys2 CBS 138 (Y1092) lys2 This study
Y1637 BG2 lys2 BG2 lys2 This study
Y1662 BG2 lys2 DCR1 AGO1 BG2 RNAi master strain, lys2 carrying P1062
(stable transformant)
This study
Y1699 Y1092 lys2 DCR1 AGO1 CBS 138 RNAi master strain, lys2 carrying P1062
(stable transformant)
This study
Y2121 BG14 ura3 DCR1 AGO1 BG14 RNAi master strain, ura3 carrying
P1062 (stable transformant)
This study
Y1663 Y1637 DCR1 AGO1 URA3
antisense-8
Y1662 Y1662 carrying P1029 This study
Y1664 Y1637 DCR1 AGO1 URA3
antisense-12
Y1662 Y1662 carrying P1029 This study
Y1665 Y1637 DCR1 AGO1 URA3
hairpin-4
Y1662 Y1662 carrying P1030 This study
Y1667 Y1637 DCR1 AGO1 URA3
hairpin-7
Y1662 Y1662 carrying P1030 This study
Y1660 Y1637 DCR1 AGO1 ADE2
antisense-5
Y1662 Y1662 carrying P1065 This study
Y1661 Y1637 DCR1 AGO1 ADE2
antisense-10
Y1662 Y1662 carrying P1065 This study
Y1671 Y1637 DCR1 AGO1 ADE2 hairpin-3 Y1662 Y1662 carrying P1066 This study
Y1672 Y1637 DCR1 AGO1 ADE2 hairpin-4 Y1662 Y1662 carrying P1066 This study
Y1673 Y1637 DCR1 AGO1 ADE2
hairpin-10
Y1662 Y1662 carrying P1066 This study
Y1843 Y1699 DCR1 AGO1 PUP1
antisense
Y1699 Y1699 carrying P1125 This study
Y2172 Y1699 DCR1 AGO1 PUP1 hairpin Y1699 Y1699 carrying P1151 This study
Y1847 Y1637 DCR1 AGO1 Y1662 Y1662 carrying empty P1061 This study
Y1848 Y1636 DCR1 AGO1 Y1699 Y1699 carrying empty P1061 This study
fluconazole resistant. As estimated in our lab, the CBS138
strain has fluconazole MIC of 129 mg/L, which is higher
than that of DSY565 (fluconazole MIC of 64 mg/L, Vale-
Silva et al., 2017). To achieve a stable integration for silencing
constructs in the genome, we targeted the 18S rDNA locus
of C. glabrata CBS 138 strain with RNAi. For a constitutive
expression level, the promoter PGK1 of C. glabrata was selected
(Supplementary Figure S1).
We constructed two recombinant plasmids carrying antisense
or hairpin constructs for the PUP1 (Supplementary Table S2).
These vectors (P1125 and P1151) were linearized with SacII
(this restriction site is present in the 18S rDNA sequence) and
transformed into CBS 138-based C. glabrata master strain Y1699
carrying both DCR1 and AGO1 genes (Table 1). The plasmid
linearization in 18S rDNA region generated homologous regions
for ends-in homologous recombination with 18S rDNA loci. To
check the stability of the plasmids’ integration into the genome,
the recombinant colonies were grown for several generations on
non-selective YPD medium. The strains were analyzed by PCR
to confirm the presence of antisense or hairpin “bullets” and
integration of both DCR1 and AGO1. Then 90% of all strains
carrying the inserts were stable for 60 generations.
Using this approach, we constructed two strains, Y1843 and
Y2172, which carry antisense and hairpin constructs for the
C. glabrata PUP1 gene, respectively. As survival in macrophages
may be one important virulence determinant of C. glabrata
(Brunke and Hube, 2013), we used a macrophage-confrontation
assay for the analysis of fitness of our mutant. In this macrophage
confrontation assay, the strains carrying the PUP1 antisense and
hairpin constructs showed decreased intracellular survival of 42%
(for antisense construct) and 29% (for hairpin construct) of
their mean values compared to the empty-vector control strain
Y1848 (Figure 2). While the silencing constructs reduced survival
comparing to the control (ANOVA, p = 0.02 and p = 0.1),
the difference between the antisense and hairpin transformants
survival was not significantly different (ANOVA, p = 0.42).
Compared to the control strain, the PUP1 gene expression was
10-fold lower in the PUP1 antisense strain, and 1000-fold lower
in PUP1 hairpin strain (Supplementary Figure S2). The ratio
of gene size to antisense region was ∼2. Our results of the
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FIGURE 2 | In C. glabrata, silencing-constructs of the putative virulence-associated gene PUP1 (CAGL0M12947g) inhibit yeast-survival in the macrophage model.
(A) M2 macrophages differentiated from peripheral-blood monocytes of five donors were infected with the three C. glabrata strains. Yeast survival was assessed by
CFU count. (B) The relative survival-rates of C. glabrata strains carrying antisense and hairpin constructs of the PUP1 gene were determined and normalized to the
control strain carrying an empty vector (Y1848, set as 100% survival and used to normalize data). The plot is based on the data of five replicates for each construct.
down regulation of PUP1 gene by silencing constructs prove that
our RNAi system can be used to study gene functions in an
infection model and show that PUP1 is required for C. glabrata
survival in macrophages.
Construction of RNAi Gene Library to
Detect New Virulence-Associated Genes
of C. glabrata
To use our RNAi system as a basis for the identification of
infection-relevant C. glabrata genes, we constructed a library
of C. glabrata genome fragments on a plasmid vector (P1226)
carrying an ARS-like sequence, which results in about 10
copies per cell (Hanic-Joyce and Joyce, 1998) (Figure 3A).
The expression cassette for genomic fragments contained the
strong constitutive promoter TEF1 and the terminator CYC1 of
C. glabrata. The resulting gene-library plasmids were isolated
from 400,000 bacterial transformants, and 40% of these carried
inserts ranging from 1 to 5 kb in size as estimated by Sau3AI
enzyme digestion of the plasmid DNA. The constructed gene
library therefore represented at least a 10× genome coverage
of C. glabrata as estimated by the number of clones and
their plasmid insert sizes. This library was used to transform
the BG2-based C. glabrata strain with the reconstituted RNAi
pathway, Y1662 (Figure 3). In this case, both sense and
antisense DNA fragments (depending on the orientation of the
ligated genomic fragments) could determine the transformant’s
phenotype. We expected that the sense fragments lead to gene
up-regulation, while the antisense fragments lead to gene down-
regulation (silencing).
RNAi Gene Library Phenotypic Screening
Identifies Putative Virulence-Associated
Genes
A total of 1080 C. glabrata strains with the gene library
were selected randomly from ∼5000 colonies obtained after
transformation, and subjected to phenotypic profiling in search
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FIGURE 3 | Cloning of putative virulence genes from a gene library. (A) Genomic DNA for gene library construction was isolated from the C. glabrata BG2 strain. The
DNA was partially digested with Sau3AI and cloned into the C. glabrata multi-copy expression vector P1226 under control of the TEF1 promoter and with CYC1
terminator. This library was transformed into the RNAi-capable C. glabrata strain Y1662. (B) 1080 transformants of Y1662 containing gene library plasmids were
plated from liquid YNB onto different media of interest (amphotericin B, fluconazole, menadione, hydrogen peroxide, SDS, bromocresol green) using a robotic
system in 384-colony format plates. The growth of colonies was monitored by the digital imaging over 96 h.
of novel virulence-related genes involved in ROS tolerance,
and antifungal drug resistance (Figure 3), attributes that help
C. glabrata survive in the host. In addition, we selected medium
with SDS for the large-scale cloning of genes responsible for
C. glabrata cell integrity, and pH indicator for monitoring the
colonies surface pH (Figure 3). Later can be explored further as
targets for the development of new antifungals to destroy the cell
or studied for its pH alteration properties in macrophages.
In the first round of screening, 1080 transformants were
analyzed for their growth capacity in two replicates at high
resolution using a robotic platform. The plating and growth
screening were carried out on solid media containing fluconazole,
amphotericin B, menadione, hydrogen peroxide, SDS, or the
pH indicator bromocresol green. As shown in Figure 4,
the C. glabrata transformant colonies varied in their growth
phenotypes with a high correlation between two replicates. In
comparison to the control medium (YNB with 2% glucose), the
addition of selected compounds in most conditions resulted in
more divergent transformant phenotypes (colony sizes) relative
to the control transformant with an empty vector (used for the
normalization and has value 1). Transformants with colony size
different to the control strain under the conditions studied are
of interest for further study, as the genes, which can contribute
to this superior or diminished growth, are potential antifungal
targets. Several transformants were resistant or sensitive to
different stress conditions (Figure 4).
The second round of screening was performed for the
sensitivity to the potent new antifungal peptides 6, 9, and 11
developed by Larsen et al. (2015). For this, we used selected
transformants with stress-related phenotypes (identified in the
first round, 139 transformants) and 54 previously untested
randomly picked up transformants. Transformants were tested in
replicate and 11 transformants proved to be sensitive or resistant
to one or all of the antifungal peptides tested (Table 2).
In total, we randomly selected 82 gene library transformants
for sequencing, all of which showed increased or decreased
stress sensitivity, and/or changed resistance to antifungal drugs
tested, for sequencing. The inserts of the isolated plasmids
were sequenced from the promoter TEF1 and the terminator
CYC1 and 24 inserts sequences, which were obtained in full,
contained one gene (or portion of a gene) in either the
sense or anti-sense orientation (Table 2). The C. glabrata
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FIGURE 4 | The gene library transformants had different growth phenotypes. (A) Relative colony size of two replicates of 1080 gene library transformants of the
RNAi-capable strain under different conditions estimated at 48 h of incubation. Colony size of transformants with the library was normalized to the control (Y1662
with empty vector, which was set to 1.0) on each plate. Conditions: 0 (no treatment), antifungals (fluconazole [50 and 400 µg/ml], amphotericin B [0.05 and
0.25 µg/ml]), ROS-generating compounds (hydrogen peroxide [3 and 12 mM], menadione [0.02 and 0.06 mM]), and surfactant (SDS, 0.0025 and 0.01%).
(B) Growth for 96 h of transformants (two replicates each) selected for sequencing on the medium with AmB (0.25 µg/ml).
CAGL0G05335g gene, (TPS2) encoding a subunit of trehalose-
6-phosphate synthase/phosphatase complex and known to be
associated with virulence in C. albicans (Van Dijck et al.,
2002), was found on two plasmids. Most of the genes isolated
were so far uncharacterized (Table 2). Potential gene functions
predicted form orthologs of identified genes in other species
cover numerous cellular processes including RNA processing
and transcription regulation, adhesins, trehalose biosynthesis,
ethanol production, protein folding, chromosome maintenance
and recombination, and metabolite transport. We also found
two clones with antisense fragments to genes, whose orthologs
in S. cerevisiae are essential: CAGL0H00891g (S. cerevisiae IQG1
encodes protein required cytokinesis (Epp and Chant, 1997), and
CAGL0A01430g [S. cerevisiae TRP5 gene encodes tryptophan
synthase and whose mutations results in tryptophan auxotrophy
(Braus, 1991)].
Seven transformants proved to be sensitive to one or to all
antifungal peptides tested (Table 2). For example, transformant
81C6 (5N2) was sensitive to peptide 6, 9, and 11 (Table 2 and
Figure 5), and was found to carry the plasmid with antisense
fragment to the C. glabrata CAGL0J02464g gene, which encodes
a putative isopeptidase, that is possibly able to directly cleave
or modify the tested peptides. Four transformants proved to be
resistant to one or to all antifungal peptides tested (Table 2).
Transformant 81E12 (2A3) was resistant to peptide 9 (Table 2
and Figure 5), and was found to carry the plasmid with sense
fragment of the C. glabrata CAGL0B01683g/TMN2 gene’s open
reading frame, which ortholog in S. cerevisiae is a membrane
protein, which take part in endosome-vacuolar trafficking. The
degradation of other antimicrobial peptides by targeting to
yeast vacuole was reported by other studies (Lis et al., 2009;
Muñoz et al., 2013).
In addition sensitivity to antifungal drugs, the transformant
3F3 displayed more acidic colony surface on medium with
pH indicator bromocresol green, as the colonies of this strain
had darker yellow color than the control strain (Figure 6A),
indicating acid pH (≤3) of 3F3 colonies. The observed properties
of 3F3 on bromocresol green could affect its survival after
phagocytosis. Sequencing of the insert of the gene library plasmid
isolated from 3F3 showed that it carried an antisense insert
of the uncharacterized gene of CAGL0K11968g of C. glabrata.
In S. cerevisiae, the gene-ortholog has a 3-hydroxyisobutyryl-
CoA hydrolase activity and a role in the stress-activated MAPK
cascade with its mutation affecting the fluid-phase endocytosis1.
Indeed, vacuolar staining revealed that as in deletion mutants
of S. cerevisiae, the down-regulation of this gene in C. glabrata
affects the vacuolar morphology (Figure 6B). We tested the
3F3 strain in our macrophage model, where it was 50% more
susceptible to killing after macrophage phagocytosis (Figure 6C).
The macrophages phagosome maturation is accompanied with
high level of ROS, and one of C. glabrata strategies to proliferate
inside the macrophages is lowering ROS (Seider et al., 2011).
Our study of 3F3 strain showed that it had lowered proliferating
properties inside the macrophages (lowered survival). The
expression of the 3F3 plasmid (antisense) was also found to
confer hydrogen peroxide sensitivity in RNAi strain but not in
wild type (Supplementary Figure S3).
In summary, using high resolution of mitotic growth
screening of gene library in RNAi strain we cloned several
putative virulence-related genes.
RNAi Gene Library Antisense Plasmids
Inhibit the Expression of Their Target
Genes
Further studies are needed to verify each isolated gene by the gene
overexpression studies or gene deletions. Moreover, the antisense
and truncated gene constructs may have off target effects on other
gene expression as observed in mammalian cells (El-Brolosy and
1www.yeastgenome.org
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TABLE 2 | Sequencing analysis of gene library plasmids.
Plasmid name
from robot
screening
Plasmid name
from manual
screening
Gene present on
the plasmid insert
Gene description
(www.candidagenome.org)
Insert orientation Phenotype
2C23, #220 81E18 CAGL0L00157g Uncharacterized, homologous to other
adhesion-like GPI-anchored proteins of
C. glabrata (EPA11, EPA19, etc.).
Antisense Fluconazole (−) Amphotericin B
(−) Menadione (−) pH
(modified) SDS (−)
2E5, #235 81C18 CAGL0E00231g Uncharacterized, putative adhesin-like
protein; contains tandem repeats and a
predicted GPI-anchor; belongs to
adhesin cluster III.
Antisense Fluconazole (−) Amphotericin B
(−) Menadione (−) SDS (−)
H2O2 (−)
2G7, #260 81E14 CAGL0I11011g Uncharacterized, putative adhesin;
belongs to adhesin cluster V.
Antisense Fluconazole (−) Amphotericin B
(−) Menadione (−) SDS (−)
H2O2 (-)
2A3, #186 81E12 CAGL0B01683g TMN2, uncharacterized, ortholog(s)
have role in cellular copper ion
homeostasis, invasive growth in
response to glucose limitation,
pseudohyphal growth, vacuolar
transport and fungal-type vacuole
membrane localization.
Sense Fluconazole (−) Menadione (−)
SDS (−) pH (modified) Peptide
9 (+) H2O2 (−) SDS (−)
2I5, #283 CAGL0G05335g TPS2, uncharacterized, ortholog(s)
have trehalose-phosphatase activity.
Antisense Fluconazole (−) Amphotericin B
(−) Menadione (−) SDS (−)
H2O2 (−)
5N2, #893 81C6 CAGL0J02464g Uncharacterized, Ortholog(s) have
SUMO-specific isopeptidase activity,
role in chromosome condensation,
mitotic spindle assembly checkpoint,
plasmid maintenance, protein
desumoylation, and nucleus
localization.
Antisense Fluconazole (−) Amphotericin B
(−) Menadione (−) SDS (−)
Peptide 6 (−) Peptide 9 (−)
Peptide 11 (−) H2O2 (−)
3F3, #430 81C4 CAGL0K11968g Uncharacterized, ortholog(s) have
3-hydroxyisobutyryl-CoA hydrolase
activity and mitochondrial ribosome
localization.
Antisense Fluconazole (−) Amphotericin B
(−) Menadione (−) SDS (−) pH
(modified) H2O2 (−)
2A5, #187 81E4 CAGL0H05049g Uncharacterized, ortholog(s) have
leucine-tRNA ligase activity, mRNA
binding activity, role in Group I intron
splicing, leucyl-tRNA aminoacylation,
mitochondrial translation and
mitochondrion localization.
Sense Fluconazole (+) Amphotericin B
(+) Menadione (+) SDS (+)
Peptide 9 (+) H2O2 (+)
2N23, #352 81C22 CAGL0D05588g Uncharacterized, ortholog(s) have role
in maturation of SSU-rRNA from
tricistronic rRNA transcript (SSU-rRNA,
5.8S rRNA, LSU-rRNA) and nucleolus,
small-subunit processome localization.
Sense Fluconazole (+) Amphotericin B
(+) H2O2 (+) Menadione (+)
SDS (+)
81N8 CAGL0A01430g Uncharacterized, putative tryptophan
synthase; protein abundance increased
in ace2 mutant cells.
Antisense Amphotericin B (−)
6D19, #966 81A16 CAGL0E00539g Uncharacterized, ortholog(s) have role
in attachment of spindle microtubules
to kinetochore involved in homologous
chromosome segregation, chromatin
silencing at rDNA, protein localization to
nucleolar rDNA repeats, rDNA
condensation.
Antisense Fluconazole (+) Amphotericin B
(+) SDS (+) Peptide 6 (+)
Peptide 9 (+) Peptide 11 (+)
6K21, #1051 81A14 CAGL0J01661g Uncharacterized, has domain(s) with
predicted transmembrane transporter
activity and role in transmembrane
transport.
Sense Fluconazole (−) Amphotericin B
(−) Menadione (−) SDS (−)
H2O2 (−)
(Continued)
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TABLE 2 | Continued
Plasmid name
from robot
screening
Plasmid name
from manual
screening
Gene present on
the plasmid insert
Gene description
(www.candidagenome.org)
Insert orientation Phenotype
3F1, #429 CAGL0M04741g Uncharacterized, ortholog(s) have
protein disulfide isomerase activity,
protein disulfide oxidoreductase activity,
protein-disulfide reductase (glutathione)
activity and role in protein folding.
Sense Amphotericin B (+) SDS (+)
4E7, #604 CAGL0K01991g Uncharacterized, has domain(s) with
predicted tRNA
(cytosine-5-)-methyltransferase activity.
Sense Fluconazole (−) Amphotericin B (−)
Menadione (−) SDS (−) H2O2 (-)
5B5, #751 81G5 CAGL0J03652g Uncharacterized, has domain(s) with
predicted ATP binding, aminoacyl-tRNA
editing activity, leucine-tRNA ligase
activity, role in leucyl-tRNA
aminoacylation and cytoplasm
localization.
Sense Fluconazole (−) Amphotericin B (−)
Peptide 9 (−)
6J23, #1040 CAGL0A03630g Uncharacterized, ortholog(s) have RNA
polymerase III general transcription
initiation factor activity, chromatin
insulator sequence binding activity and
role in transcription initiation from RNA
polymerase III promoter.
Sense Fluconazole (−) Amphotericin B (−)
Menadione (−) H2O2 (−)
3I5, #467 81I15 CAGL0I07843g ADH1, Putative alcohol dehydrogenase
isoenzyme III; increased protein
abundance in azole resistant strain.
Sense Fluconazole (−) Amphotericin B (−)
Menadione (−) SDS (−) Peptide 6
(−) Peptide 9 (−) Peptide 11 (−)
H2O2 (−)
3C9, #397 81I21 CAGL0A00781g Uncharacterized, has domain(s) with
predicted zinc ion binding activity.
Sense Fluconazole (−) Amphotericin B (−)
Menadione (−) SDS (−) Peptide 9
(−) H2O2 (−)
82H20 CAGL0B05049g Uncharacterized, ortholog(s) have
ubiquitin-protein transferase activity and
role in double-strand break repair via
non-homologous end joining,
double-strand break repair via
synthesis-dependent strand annealing.
Sense Amphotericin B (−) Peptide 6 (−)
Peptide 9 (−) Peptide 11 (−)
82N22 CAGL0H00891g Uncharacterized, ortholog(s) have actin
filament binding, calmodulin binding
activity.
Antisense Amphotericin B (−) Peptide 6 (−)
Peptide 9 (−) Peptide 11 (−)
81E20 CAGL0G05335g TPS2, uncharacterized, ortholog(s)
have trehalose-phosphatase activity.
Antisense Amphotericin B (−)
82M12 CAGL0L13392g Protein of unknown function. Sense Amphotericin B (−) Peptide 6 (+)
Peptide 9 (+) Peptide 11 (+)
83K4 CAGL0D06446g STT4, uncharacterized, ortholog(s) have
1-phosphatidylinositol 4-kinase activity.
Sense Fluconazole (+)
83K11 CAGL0H07623g Uncharacterized, ortholog(s) have role
in meiotic gene conversion, reciprocal
meiotic recombination.
Antisense Amphotericin B (−) Peptide 6 (−)
“#”, location on the graph, Figure 4. “+”, resistant. “−”, sensitive.
Stainier, 2017; Ma et al., 2019; Wilkinson, 2019), and studying
the global gene expression of these strains could give more
information on this in future studies. In this study, to rule-out
the possibility of off-target gene inhibitions we have investigated
the target gene expression of 10 antisense constructs in both wild
type and RNAi strains.
For this purpose we took ten gene library antisense plasmids
(2C23, 2E5, 81E20, 6D19, 3F3, 2I5, 82N22, 81N8, 83K11, and
2G7) and transformed them into the wild type and RNAi strains.
Two transformants of each plasmid were selected for the analysis.
The RNA was extracted from their cultures grown in YNB
with 2% glucose and gene expression was studied by qRT-PCR
(Figure 7 and Supplementary Figure S4). Plasmids 2C23, 2E5,
81E20, 2I5, and 82N22 had stronger gene expression inhibition in
RNAi strain than in WT. Plasmids 6D19, 3F3, 81N8, 83K11, and
2G7 proved to inhibit the target genes in RNAi strain but not in
the WT strain (Figure 7). This suggests that the gene inhibition
is indeed mediated through RNAi. Phenotypes observed during
the robotics screening were re-confirmed for most plasmids
after the re-transformation (Supplementary Figure S3). While
some of the phenotypes were unique to RNAi transformants
(H2O2 sensitivity in 2I5, 3F3, 82N22, and 81E20), 2I5 conferred
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FIGURE 5 | Growth of gene library transformants of RNAi strain on antifungal peptides (#6, #9, #11) and amphotericin B (AmB). The transformants, which displayed
sensitivity or resistance to the compounds tested were selected for sequencing (arrowed).
the amphotericin resistance to both RNAi and wild type strain
(Supplementary Figure S3).
DISCUSSION
The yeast C. glabrata is an important opportunistic human
pathogen, which has become of interest over recent decades,
particularly due to its increasing occurrence and resistance to
antifungal drugs.
Unlike for S. cerevisiae and C. albicans, there are no extensive
genetics toolboxes available for C. glabrata and thus this yeast
remains poorly studied. Gene deletions in this yeast for gene
function elucidations are not easy to obtain. With a higher
rate of non-homologous recombination in C. glabrata than
that in S. cerevisiae (Cormack and Falkow, 1999; Corrigan
et al., 2013), longer homology regions are required for more
efficient gene knockouts in C. glabrata; haploid asexual nature
of C. glabrata prohibits many techniques based on mating
developed for S. cerevisiae. In this study, we developed a
new tool for C. glabrata based on RNA interference (RNAi),
which relies on gene silencing through double-stranded RNA
intermediates and siRNA. This ancient mechanism of protection
from foreign DNA and chromatin organization is lost in
Hemiascomycetes (Axelson-Fisk and Sunnerhagen, 2006) with
the exception of Saccharomyces castellii (Drinnenberg et al.,
2009). We therefore cloned the DCR1 and AGO1 genes from
S. castellii and overexpressed them in C. glabrata together
with silencing constructs. Judging from our data on silencing
of metabolic genes (endogenous ADE2 and URA3 genes), the
introduced RNAi pathway is functional and can be applied
to additional genes of interest in this yeast. We found that
gene silencing was stronger with hairpin compared to antisense
constructs in this study similarly to Drinnenberg et al. (2009).
Although our data indicate that the CUP1 promoter used for
RNAi is leaky, the antisense constructs resulted in decreased gene
expression and detectable phenotypes only upon its induction
by copper. In contrast, the hairpin constructs displayed high
inhibition of gene expression regardless of the CUP1 promoter
induction, which suggests that the designed hairpins are very
effective in our system.
Our RNAi tool proved to be active when we tested it with an
established virulence-associated gene CAGL0M12947g (PUP1) of
C. glabrata, which was shown by deletion to be important for a
survival in a mouse model (Ferrari et al., 2011). Here, we showed
that down-regulation of this gene affects survival in human
macrophages. Its ortholog (RCI37/YIL077C) is poorly studied in
S. cerevisiae. Although it is known to localize in the mitochondria
and interact with the respiratory chain (Morgenstern et al.,
2017), the mechanistic connections of its C. glabrata ortholog to
virulence remain unknown.
We were interested to apply the developed RNAi for the
discovery of new virulence-associated genes of C. glabrata. We
did this by using the RNAi strain with a gene library as the
basis for screening of virulence-related phenotypes and the
identification of responsible genes. To this end we created a
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FIGURE 6 | Candida glabrata CAGL0K11968g contributes to vacuolar morphology and survival in macrophages. (A) On the medium with pH indicator bromocresol
green the 3F3 strains had darker yellow color than control strain, indicating more acidic pH. (B) Fluorescent microscopy images of C. glabrata strains after staining
showing abnormal vacuolar morphology of the 3F3 strain. (C) The transformant 3F3, which carries an antisense CAGL0K11968g gene, displayed 50% loss of
viability in our macrophage model. The experiment was performed in four replicates with cells originating from blood of two donors. The plot is based on data of four
replicates. The control strain data (CFU) was set as 100% and used to normalize data. According to Poisson Regression analysis of raw data, the 3F3 strains CFU
response was significantly different (∗∗∗p-value ≤ 0.0005).
library of random genome fragments in the expression vector.
In contrast to hairpin constructs, this approach is feasible on the
genomic level (the library represents 10-fold genome coverage),
and we can assume that a significant portion of clones will
carry the antisense regions of genes to induce RNAi. Since the
inhibitory effect of the antisense constructs was less efficient than
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FIGURE 7 | The target genes expression studies of the transformants of RNAi and wild type strain carrying antisense gene library plasmids. Y-axis – logarithmic
scale. RNAi strain was Y1662, and the wild type was Y1637, which were newly re-transformed with plasmids. Antisense plasmids: 1 – 2C23 (CAGL0L00157g gene),
2 – 2E5 (CAGL0E00231g gene), 3 – 81E20 (CAGL0G05335g gene), 4 – 6D19 (CAGL0E00539g gene), 5 – 3F3 (CAGL0K11968g gene), 6 – 2I5 (CAGL0G05335g
gene), 7 – 82N22 (CAGL0H00891g gene), 8 – 81N8 (CAGL0A01430g gene), 9 – 83K11 (CAGL0H07623g gene), and 10 – 2G7 (CAGL0I11011g gene). The
untreated controls were used to calculate gene expression fold change: RNAi and wild type carrying empty vector (P1226). Primer pair ACT1-1 and ACT1-2 was
used for ACT1 gene.
hairpins in our model and required a high expression level, the
gene library was constructed using the strong constitutive TEF1
promoter and a multi-copy vector.
Our primary interest was to discover genes, which affect
C. glabrata resistance to antifungal drugs, and to stress conditions
that C. glabrata may face during survival in macrophages.
Therefore, we selected the following conditions for cell growth
in vitro, which have overlap in their targets in yeast. In our
screening we selected fluconazole and amphotericin B, which are
both antifungal drugs currently in use against candidiasis, and
which target the plasma membrane. Although the mechanism
of action of many azole drugs and resistance to them are
quite extensively studied (Vale-Silva and Sanglard, 2015), the
molecular mechanism of amphotericin B action and resistance
remains poorly understood. We also tested hydrogen peroxide
and menadione since ROS are elevated upon amphotericin B
exposure (Mesa-Arango et al., 2014), and are produced inside
the macrophages phagosomes (Seider et al., 2014), and resistance
against ROS is important for pathogen survival. SDS was tested
to mimic damage to the plasma membrane. In addition, we
used new antifungal drugs for the C. glabrata gene library
screening including three peptidomimetics with an arginine-
[β-(2,5,7-tri-tert-butylindol-3-yl)alanine]-arginine motif, which
were recently developed (Larsen et al., 2015), and are effective
against S. cerevisiae as well as Zygosaccharomyces bailii, known
to spoil food. Interestingly, C. glabrata was previously shown to
be resistant to these peptides (Larsen et al., 2015) and finding the
resistance genes in pathogenic yeasts can help to develop potent
antifungals further.
The frequent and large size differences of transformants
colonies in our screening indicated that a broad range
of genes was covered by the RNAi library strains. We
selected representative resistant and sensitive transformants for
sequencing of their plasmid inserts to determine the original
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genome loci. Using this approach, we found that several positive
clones of our RNAi library corresponded to putative virulence-
associated genes. This shows that our approach allows us to
recover genes with relevance for C. glabrata pathobiology, which
can be exploited further for the development of treatments for
C. glabrata infections.
The gene down-regulation and expression of truncated genes
might affect the expression of other genes in the genome, their
genes network as described for mammalian cells (El-Brolosy and
Stainier, 2017; Ma et al., 2019; Wilkinson, 2019). This effect,
genetic compensation, is also common for gene knockouts in
yeasts (He and Zhang, 2006; Teng et al., 2013). The expression of
antisense constructs spanning the coding regions in S. cerevisiae
from the plasmid vectors were reported to inhibit the ATH1
and CAR1 gene expression (Park et al., 2001; Jung and Park,
2005) suggesting the natural antisense interference without RNAi
(Donaldson and Saville, 2012). The whole genome sequencing
and global gene expression profiling can give more information
on any off-target effects of isolated gene library clones in the
future studies. When we analyzed ten antisense constructs, all 10
down-regulated the target genes, and 5 of 10 worked through the
RNAi because they did not down-regulate the gene expression in
the wild type strain without RNAi pathway.
Three of the genes identified in our screen were
predicted glycosylphosphatidylinositol (GPI)-anchored
proteins and adhesins (CAGL0L00157g, CAGL0E00231g, and
CAGL0I11011g), and the expression of their antisense regions
leads to sensitivity to fluconazole, amphotericin B, menadione,
hydrogen peroxide, and SDS. GPI-anchored proteins are
abundant membrane and cell wall proteins with multiple roles,
and their biosynthesis is reportedly linked ergosterol biosynthesis
and azole drug response, Ras signaling (Yadav et al., 2014). The
GPI-anchored proteins are therefore important antifungal
targets, and are in the focus of drug discovery studies (Mann
et al., 2015). It is important to note that the antisense region of
the 2C23 isolate of our study included a part of the GPI-anchored
protein transmembrane domain (CAGL0L00157g), which is a
fragment of 17 other GPI-genes sequences in the C. glabrata
genome. This suggests that the construct affected several GPI
proteins, likely resulting in altered plasma membrane structure.
The 6K21 strain, which was sensitive to antifungals
and ROS, carried the overexpression plasmid for a sense
fragment of transporter gene CAGL0J01661g, whose ortholog in
S. cerevisiae (YPR011C) encodes a mitochondrial transporter for
adenosine 5′-phosphosulfate (APS) and 3′-phospho-adenosine
5′-phosphosulfate (PAPS), the deletion of whish causes the
decreased glutathione and methionine levels and temperature
sensitive phenotype (Todisco et al., 2014), and glutathione is
known ROS scavenger (Jamieson, 1998).
Our results point at the TPS2 gene, encoding trehalose-6
phosphate phosphatase of C. glabrata, as a potential drug target
with virulence-associated roles in this yeast. The TPS2 antisense
construct expression resulted in sensitivity to fluconazole,
amphotericin B, and other stressors. The deletion of TPS2 in
both S. cerevisiae and C. albicans causes the accumulation of
increased amounts of trehalose-6 phosphate upon stress, which
is toxic to the cell, and results in thermo-sensitive phenotype
(De Virgilio et al., 1993; Van Dijck et al., 2002). In C. albicans, it
was also found to reduce the virulence as the survival of infected
mice in systemic infection model was increased (Van Dijck et al.,
2002). Indeed, the deletion of this gene leads to impaired growth
in C. albicans, and other species, and the gene product itself is
considered as a potential target for antifungal therapy (Van Dijck
et al., 2002; Pianalto and Alspaugh, 2016).
The transformant 3I5 carried a gene library plasmid with
a complete ADH1 open reading frame in the sense direction.
It proved to be sensitive to fluconazole, amphotericin B,
peptides, SDS, and reactive oxygen species. The ADH1 gene is
encoding alcohol dehydrogenase, responsible for the conversion
of acetaldehyde to ethanol. In C. albicans, the expression
of the ADH1 and azole resistance is inversely correlated in
clinical isolates (Siikala et al., 2011). On the contrary, increased
abundance of the Adh1 protein was previously observed in an
azole resistant strain of C. glabrata (Rogers et al., 2006). Since we
do not have the data on the ADH1 expression in 3I5 strain, further
study is needed.
Due to their low toxicity, the peptidomimetics are potent
antifungal drugs (Larsen et al., 2015). A mode of action of
these peptides is likely the interaction with sphingolipids, as
determined by the analysis of deletion mutants’ library in
S. cerevisiae (Larsen et al., 2015). Larsen et al. (2015) pointed
out that higher resistance in pathogenic yeasts (C. albicans
and C. glabrata) to these compounds might be due to the
secretion of extracellular proteases, which sequester or degrade
the antifungals. One of the isolated C. glabrata antisense plasmids
carried part of the CAGL0J02464g gene, whose orthologs have
SUMO (Small Ubiquitin-like Modifier)-specific isopeptidase and
protein deSUMOylation activities. The encoded isopeptidase
could be important for the resistance to peptidomimetics in
this yeast and could be involved in their direct cleavage, in
support of the hypothesis proposed by Larsen et al. (2015).
In addition, fragments of two putative aminoacyl-tRNA genes
were found with our system affecting the peptidomimetics
resistance. We hypothesize that they could directly interact with
peptidomimetics or their targets by acylating them. Aminoacyl-
tRNA dependent acylation is involved in several cellular
processes and resistance to antifungal peptides reported in other
species (Raina and Ibba, 2014). Acylation of membrane lipids
is known to change the membrane surface and subsequently
the affinity of the membrane to antifungal peptides in other
species (Ernst and Peschel, 2011; Raina and Ibba, 2014). The
direct acylation of macromolecules using aminoacyl-tRNA can
change their activity, recognition or directs them to degradation
(Katz et al., 2016).
Taking a step further, we validated the importance of one of
the identified target in the macrophage model. We confirmed the
vital importance of the C. glabrata CAGL0K11968g gene affecting
colony pH and vacuolar function with this screening method.
With the antisense construct for this gene the C. glabrata strain
was less viable upon exposure to human macrophages.
We have thus established a working RNAi system for the
investigation of C. glabrata pathobiology. Our initial testing
showed that the system can be used to interfere with the
expression of a broad range of genes, including those assumed
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to be essential for C. glabrata. The RNAi strains can be
used in in vitro stress tests and in interaction with immune
cells, which will be invaluable in attributing functions to the
many genes of C. glabrata, which are unannotated so far.
Our screening of a RNAi library with genome fragments is
a first step into that direction. Especially, as this method
enables us to tackle new genes, which are central for
fungal growth and survival, we believe that it will allow
us to find important new potential targets for C. glabrata
antifungals, a yeast that is notorious for its inherent and
acquired resistances.
MATERIALS AND METHODS
Growth Conditions
All strains used in this study were grown in rich medium
(YPD [yeast extract 1%, peptone 2%, glucose 2%, Bactoagar
2%] or synthetic minimal medium (YNB [yeast nitrogen
base without amino acid and ammonium sulfate] 1.9 g/L,
glucose 2%, ammonium sulfate 0.5%) at 25◦C, unless stated
otherwise. For the uracil-deficient mutant BG14, 50 mg/L
uracil was added to the YNB medium. For the lysine-deficient
mutants, 40 mg/L lysine was added to the minimal medium.
C. glabrata transformants carrying plasmids with the LYS2
gene as a selectable marker were selected and propagated
on YNB medium. For C. glabrata transformants carrying the
Streptoalloteichus hindustanus ble gene as a selective marker,
200 µg/ml of zeocin was added to the YPD medium. For the
induction of the CUP1 promoter, 0.05 mM CuSO4 was added
to the YNB medium.
For gene library yeast transformants different compounds
were added to YNB medium as follows: amphotericin B (0.05
and 0.25 µg/ml), fluconazole (50 and 400 mg/L), SDS (0.01 and
0.0025%), hydrogen peroxide (3 and 12 mM), menadione (0.02
and 0.06 mM), and antifungal peptidomimetics (peptide 6 [H-
Arg-Tbt-Arg-Phe-NH2], 9 [H-Arg-Tbt-Arg-hPhe-NH2], and 11
[H-Arg-Tbt-Arg-[NPhe]-NH2] (Larsen et al., 2015) at 25 µg/ml.
Gene library transformants were propagated at 37◦C.
RNA Extraction and qRT-PCR
Total RNA was extracted from the C. glabrata cultures grown
in selective media (supporting plasmids propagation) using
the PureLink RNA Mini Kit (Thermo Fisher Scientific).
The concentration and purity of RNA were determined by
NanoDrop spectrophotometer. The isolated RNA was treated
with DNase I (RNase-Free DNase Set, Qiagen) according
to the manufacturer’s recommendations. The RNA integrity
was checked by electrophoresis using precast RNA MOPS
agarose gels (Sigma-Aldrich). Five microgram of pure RNA
was used for the synthesis of cDNA. The SuperScript III
Reverse Transcriptase kit with RNaseOUT Ribonuclease
Inhibitor and random primers (Thermo Fisher Scientific)
was used. The cDNA produced was used as a template
with gene-specific primers in qRT-PCR reactions with the
SYBR GreenER qPCR SuperMix (Thermo Fisher Scientific).
qRT-PCRs were run in duplicate in the RotorGene 2000
cycler (Corbett Research) under the conditions specified by
Thermo Fisher Scientific. The take off and amplification
values were obtained using the RotorGene 2000 software.
The β-actin gene was treated as the endogenous reference
gene (housekeeping gene), while Y1848 was used as untreated
strain. Primer pairs for the 3′-region of the gene ORFs of
interest of C. glabrata were used in qRT-PCR experiments
as follows for the: ACT1 (OP33 and OP34; ACT1-1 and
ACT1-2), ADE2 (OP31 and OP32), URA3 (OP27 and OP28),
PUP1 (947-1 and 947-2), CAGL0L00157g (157-1 and 157-
2), CAGL0E00231g (231-3 and 231-4), CAGL0G05335g
(5335-3 and 5335-4), CAGL0E00539g (539-1 and 539-
2), CAGL0K11968g (968-1 and 968-2), CAGL0H00891g
(891-1 and 891-2), CAGL0A01430g (1430-3 and 1430-4),
CAGL0H07623g (7623-1 and 7623-2), and CAGL0I11011g
(11-1 and 11-2) (Supplementary Table S1). The gene
expression fold change was calculated by the 11Ct method
(Livak and Schmittgen, 2001).
Macrophage Culture and Infection With
Yeast
Human monocyte-derived macrophages (hMDMs) were
prepared according to the protocol used before (Seider
et al., 2011, 2014). Monocytes were isolated from human
peripheral blood (donated by healthy volunteers with
written consent) with CD14 magnetic beads by automated
cell sorting (autoMACs, MiltenyiBiotec). CD14-positive
monocytes differentiated to M2 macrophages for 7 days
in RPMI1640 media with L-glutamine (Thermo Fisher
Scientific) with 10% heat-inactivated FCS (Bio&Sell GmbH),
and with 50 ng/ml recombinant human macrophage colony
stimulating factor (rh M-CSF; Immunotools). Adherent
MDMs were detached with 10 mM EDTA in PBS and
seeded in 96-well plates (4 × 104 hMDMs/well) in RPMI
with 50 ng/ml rh M-CSF and 10% FCS and incubated
overnight. Prior macrophage infection yeast cells from a
stationary YNB culture were washed three times with PBS.
M2 macrophages were infected by adding the yeast cells
at multiplicity of infection of one (MOI 1) in RPMI w/o
FCS. The cells were further diluted and incubated for 3 h
at 5% CO2 and 37◦C. Unattached yeast cells were removed
by washing the macrophages two times with 60 µl PBS.
Next, 20 µl of 0.5% Triton X-100 was added to lysate the
macrophages, and incubated 10 min under gentle shaking.
After the incubation, cells were diluted, plated on YPD, and
incubated at 37◦C for 1 day. After incubation, the yeast CFU
were counted. The reference strain Y1848 carrying empty
vector was used to normalize obtained data and was set to
100% survival.
Robotics Screening
Individual transformants of the C. glabrata RNAi strain
(Y1662) containing the gene library plasmids were grown
overnight in flat bottom polystyrene 96-well plates in
200 µl of liquid YNB at 37◦C (12 plates in total). The
next day, yeast transformants were plated onto the
solid media YNB supplemented with antifungal drugs
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[amphotericin B (0.05 and 0.25 µg/ml) or fluconazole (50 and
400 µg/ml)], ROS generating compounds [menadione (0.02 and
1 0.06 mM) and hydrogen peroxide (3 and 12 mM)], surfactant
(SDS 0.01 and 0.0025%) and a pH indicator (bromocresol
green 0.01 g/ml, YNB medium pH was adjusted to 4.5) using
a robotic system (Siger RoToR HDA robot). Each 96-well
plate liquid culture was plated on solid medium in duplicate,
and four were combined onto one 384 format solid medium
plate. The colonies growth was scored by the colony size
in pixels from the digital images of the plates during 96 h
of incubation.
Vacuolar Staining and Fluorescent
Microscopy
Cells were re-suspended in 10 mM HEPES buffer pH 7.4
supplemented with 5% glucose. The fluorescent dye CMAC-
Ala-Pro (7-amino-4-chloromethylcoumarin, l-alanyl-l-proline
amide, Yeast Vacuolar Marker Sampler Kit [Thermo Fisher
Scientific]) was added to the cell suspension at 100 µM and
then incubated in the dark for 30 min. The staining was
visualized by fluorescent microscopy (automated inverted wide-
field microscope Observer Z1 [Carl Zeiss] equipped with a
sCMOS camera).
Statistical Analysis
The software packages R (Version 1.1.463– ©2009–2018
RStudio, Inc.), JMP R©, Pro 13.0.0 (SAS Institute Inc., Cary,
NC, United States, 1989–2019) and Minitab R©18.1, were used to
analyze the obtained data.
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